Malaysia · Delayed Price · Currency is MYR KLSE:HSPLANT Statistics
Total Valuation
KLSE:HSPLANT has a market cap or net worth of MYR 1.68 billion. The enterprise value is 1.09 billion.
| Market Cap | 1.68B |
| Enterprise Value | 1.09B |
Important Dates
The next estimated earnings date is Monday, August 24, 2026.
| Earnings Date | Aug 24, 2026 |
| Ex-Dividend Date | Mar 10, 2026 |
Share Statistics
KLSE:HSPLANT has 799.69 million shares outstanding.
| Current Share Class | 799.69M |
| Shares Outstanding | 799.69M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.99% |
| Owned by Institutions (%) | 11.93% |
| Float | 211.54M |
Valuation Ratios
The trailing PE ratio is 14.95 and the forward PE ratio is 9.61. KLSE:HSPLANT's PEG ratio is 1.33.
| PE Ratio | 14.95 |
| Forward PE | 9.61 |
| PS Ratio | 2.35 |
| PB Ratio | 0.80 |
| P/TBV Ratio | 0.80 |
| P/FCF Ratio | 12.54 |
| P/OCF Ratio | 8.10 |
| PEG Ratio | 1.33 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.09, with an EV/FCF ratio of 8.12.
| EV / Earnings | 9.68 |
| EV / Sales | 1.52 |
| EV / EBITDA | 4.09 |
| EV / EBIT | 6.10 |
| EV / FCF | 8.12 |
Financial Position
The company has a current ratio of 12.73, with a Debt / Equity ratio of 0.03.
| Current Ratio | 12.73 |
| Quick Ratio | 11.16 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.27 |
| Debt / FCF | 0.54 |
| Interest Coverage | 54.12 |
Financial Efficiency
Return on equity (ROE) is 5.45% and return on invested capital (ROIC) is 9.21%.
| Return on Equity (ROE) | 5.45% |
| Return on Assets (ROA) | 4.39% |
| Return on Invested Capital (ROIC) | 9.21% |
| Return on Capital Employed (ROCE) | 7.11% |
| Weighted Average Cost of Capital (WACC) | 3.32% |
| Revenue Per Employee | 89,786 |
| Profits Per Employee | 14,100 |
| Employee Count | 7,968 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 4.68 |
Taxes
In the past 12 months, KLSE:HSPLANT has paid 33.63 million in taxes.
| Income Tax | 33.63M |
| Effective Tax Rate | 23.04% |
Stock Price Statistics
The stock price has increased by +15.47% in the last 52 weeks. The beta is -0.17, so KLSE:HSPLANT's price volatility has been lower than the market average.
| Beta (5Y) | -0.17 |
| 52-Week Price Change | +15.47% |
| 50-Day Moving Average | 2.24 |
| 200-Day Moving Average | 2.16 |
| Relative Strength Index (RSI) | 34.81 |
| Average Volume (20 Days) | 561,260 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:HSPLANT had revenue of MYR 715.42 million and earned 112.35 million in profits. Earnings per share was 0.14.
| Revenue | 715.42M |
| Gross Profit | 264.24M |
| Operating Income | 178.22M |
| Pretax Income | 145.97M |
| Net Income | 112.35M |
| EBITDA | 238.79M |
| EBIT | 178.22M |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 665.11 million in cash and 72.79 million in debt, with a net cash position of 592.32 million or 0.74 per share.
| Cash & Cash Equivalents | 665.11M |
| Total Debt | 72.79M |
| Net Cash | 592.32M |
| Net Cash Per Share | 0.74 |
| Equity (Book Value) | 2.09B |
| Book Value Per Share | 2.61 |
| Working Capital | 769.12M |
Cash Flow
In the last 12 months, operating cash flow was 207.42 million and capital expenditures -73.52 million, giving a free cash flow of 133.90 million.
| Operating Cash Flow | 207.42M |
| Capital Expenditures | -73.52M |
| Depreciation & Amortization | 60.57M |
| Net Borrowing | -13.47M |
| Free Cash Flow | 133.90M |
| FCF Per Share | 0.17 |
Margins
Gross margin is 36.93%, with operating and profit margins of 24.91% and 15.70%.
| Gross Margin | 36.93% |
| Operating Margin | 24.91% |
| Pretax Margin | 20.40% |
| Profit Margin | 15.70% |
| EBITDA Margin | 33.38% |
| EBIT Margin | 24.91% |
| FCF Margin | 18.72% |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 3.64%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 3.64% |
| Dividend Growth (YoY) | -39.20% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 54.10% |
| Buyback Yield | n/a |
| Shareholder Yield | 3.64% |
| Earnings Yield | 6.69% |
| FCF Yield | 7.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KLSE:HSPLANT has an Altman Z-Score of 3.97 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.97 |
| Piotroski F-Score | 4 |